I take one issue with that thought process. As an OTC stock, how else are they supposed to get investors to jump on board, increase trading volume, and subsequently share price? Most NASDAQ and NYSE traders ignore the OTC. Most of those traders won't bat an eye to a little news blip about an OTC signing a commercial agreement. We'll need plenty of OTC trader visibility when they sign a commercial agreement, especially until they file a full quarter of revenue so analysts can start evaluating QMCs financials in order to estimate a target share price. After legit analysts start covering QMC, then we might get NASDAQ and NYSE traders looking this way.